Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2025-12-24 @ 5:45 PM
NCT ID:
NCT06894368
Eligibility Criteria:
Inclusion Criteria:
* Presenting a primary diagnosis of an emotional disorder with mild or moderate severity, including the following disorders based on DSM-5 categories: Depressive Disorders (Major Depressive Disorder and Persistent Depressive Disorder), Anxiety Disorders (Specific Phobia, Panic Disorder, Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder), Obsessive-Compulsive and Related Disorders (including Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania and Excoriation (Skin-Picking) Disorder), Trauma and Stressor-Related Disorders (Reactive Attachment Disorder, Post-Traumatic Stress Disorder, Acute Stress Disorder and Adjustment Disorders), Dissociative Disorders (Dissociative Identity Disorder, Depersonalization/Derealization Disorder) and Somatic Symptom and Related Disorders (Somatic Symptom Disorder and Illness Anxiety Disorder). Specified and unspecified disorders from the above categories were also included.
* Being 11-18 years of age
* Being proficient in Spanish
* The adolescent being able to attend the treatment sessions
* At least one of the adolescent's parents or legal guardians being able to attend the parents' treatment sessions
* If the participant was taking psychiatric medication, the dose was required to remain stable for at least 1 month before the start of treatment and throughout it
Exclusion Criteria:
* Presenting self-harm or suicidal ideation in a moderate or severe degree
* Presenting certain of the following clinical conditions (either as a main or comorbid diagnosis): Neurodevelopmental Disorders (Intellectual Disability or Autism Spectrum Disorder); Disruptive, Impulse-Control and Conduct Disorders; Eating Disorders; Psychotic Spectrum Disorders or psychotic-type symptoms,; Substance Abuse Disorders (excluding cannabis, coffee and/or nicotine); high severity Emotional Disorders; and Bipolar Disorders
* The characteristics or severity of the symptoms presented by the adolescent requiring an individual intervention or one adapted to the specific clinical condition
* Be receiving public or private psychological treatment during the UP-A program
* Suffering from a serious medical illness that made the adolescent's participation in the treatment program unsustainable
* The participant, or if under 16 years of age, his or her parents, having refused to sign the informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
11 Years
Maximum Age:
18 Years
Study:
NCT06894368
Study Brief:
Protocol Section:
NCT06894368